Clinical Trials Browser

Phase 2 × Urachal cancer × 90 days × Clear all

NCT07309770 2025-12-30

Trastuzumab Rezetecan in Advanced Solid Tumors Refractory to Standard Therapies

Phase 2 Recruiting

Urachal cancer, Paget Disease, Extramammary